()
()

Scandinavian ChemoTech AB (publ) performs treatments at Makati Medical Center in the Philippines

Press release
Lund February 17 2017

Scandinavian ChemoTech AB (publ) performs treatments at Makati Medical Center in the Philippines

On February 15 2017 ChemoTech began their evaluation treatments with the company’s product IQWaveTM at Makati Medical Center (MMC) in Manila, which the company recently signed a letter of intent with. This is the second hospital in the Philippines in less than a week which has begun the process.

”I am hopeful and excited to duplicate in our patients the good results of the treatment using the Dynamic-ElectroEnhanced Chemotherapy. This could very well be an answer to the unmet needs of our selected patients with breast cancer, head- and neck cancer for whom we today do not have any treatment methods,” says Dr Maria Belen E. Tamayo, medical oncologist at MMC.

”The successful treatments strengthens ChemoTech’s position in the Philippines and I look forward to continue to build strong partnerships with the hospitals in this country”, says Mohan Frick, CEO at ChemoTech.

During the training, three oncologists and a nurse became certified users of the IQWave™ Dynamic-ElectroEnhanced Chemotherapy™.

”Now we look forward to use this success to launch the IQWave™ for all major cancer hospitals, initially in Manila”, says Mohan Frick who has been at location in Manila during this eventful week.

MMC is owned by the Philippine listed company Metro Pacific Investments (MPIC). They own a total of 13 hospitals in the Philippines after their recent acquisition of another hospital.

For more information, please contact:
Mohan Frick, CEO
+ 46 (0)10-218 93 00
info@chemotech.se

Scandinavian ChemoTech AB (publ)
www.chemotech.se

This information is such information which Scandinavian ChemoTech AB (publ) is obligated to make public according to EU’s market abuse regulation and the law of securities market. The information was submitted by the agency of above stated contact persons, to be made public on Wednesday February 15th 2017 at 13.00 (CET).

ChemoTech is a young and dynamic life science corporation which rests on a great medical expertise and technical knowledge. Our latest launch of the IQWaveTM is an innovation in electro chemotherapy, which gently provides an utmost effective treatment of many types of tumors. We have our head office in the IDEON Science Park in Lund and we are in the middle of the stimulating meeting between Skåne University Hospital and Medicon Village. ChemoTech’s stocks (CMOTEC B) are listed at NASDAQ First North in Stockholm and Västra Hamnen Corporate Finance AB is the company’s Certified Adviser.

Comments are closed.